Skandinaviska Enskilda Banken (SEB)
ANAB icon

Skandinaviska Enskilda Banken (SEB)’s AnaptysBio ANAB Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-145,191
Closed -$4.45M – 716
2025
Q3 		$4.45M Buy
145,191
+111,668
+333% +$2.56M 0.02% 435
2025
Q2 		$744K Hold
33,523
– – ﹤0.01% 675
2025
Q1 		$623K Buy
+33,523
New +$559K ﹤0.01% 672

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ANAB Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of AnaptysBio (ANAB) in Q4 2025, closing a stake of 145,191 shares — an estimated $4.45M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ANAB in Q1 2025 and held it in 3 quarters. The position peaked at $4.45M in Q3 2025. 179 funds tracked by Wall St. Rank hold ANAB as of Q4 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining AnaptysBio position as of Q4 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 145,191 AnaptysBio shares in Q4 2025, an estimated $4.45M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in AnaptysBio in Q1 2025 and held it in 3 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s AnaptysBio position peaked at $4.45M in Q3 2025.
  • 179 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.